The product of this gene, P2Y11, belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is coupled to the stimulation of the phosphoinositide and adenylyl cyclase pathways and behaves as a selective purinoceptor. Naturally occurring read-through transcripts, resulting from intergenic splicing between this gene and an immediately upstream gene (PPAN, encoding peter pan homolog), have been found. The PPAN-P2RY11 read-through mRNA is ubiquitously expressed and encodes a fusion protein that shares identity with each individual gene product.
^Communi D, Govaerts C, Parmentier M, Boeynaems JM (Jan 1998). "Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase". J Biol Chem272 (51): 31969–73. doi:10.1074/jbc.272.51.31969. PMID9405388.
Communi D, Suarez-Huerta N, Dussossoy D, et al. (2001). "Cotranscription and intergenic splicing of human P2Y11 and SSF1 genes". J. Biol. Chem.276 (19): 16561–6. doi:10.1074/jbc.M009609200. PMID11278528.
Moore DJ, Chambers JK, Wahlin JP, et al. (2001). "Expression pattern of human P2Y receptor subtypes: a quantitative reverse transcription-polymerase chain reaction study". Biochim. Biophys. Acta1521 (1–3): 107–19. doi:10.1016/S0167-4781(01)00291-3. PMID11690642.
Duhant X, Schandené L, Bruyns C, et al. (2002). "Extracellular adenine nucleotides inhibit the activation of human CD4+ T lymphocytes". J. Immunol.169 (1): 15–21. doi:10.4049/jimmunol.169.1.15. PMID12077223.
Moreschi I, Bruzzone S, Nicholas RA, et al. (2006). "Extracellular NAD+ is an agonist of the human P2Y11 purinergic receptor in human granulocytes". J. Biol. Chem.281 (42): 31419–29. doi:10.1074/jbc.M606625200. PMID16926152.